City

Arecibo (1)

Bethesda (1)

Beverly Hills (1)

Fargo (1)

Houston (1)

McAllen (1)

Miami (1)

Pensacola (1)

Tehran (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Nanoscope Therapeutics Inc. (1)

National Eye Institute (NEI) (1)

Tehran University of Medical Sciences (1)

Collaborator

Intervention

autologous stem cell transplantation (1)

gene therapy product-vmco-010 (1)

sham injection (1)

Study Documents

Intervention Type

biological (2)

procedure (1)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (2)

Observational (1)

retinitis

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham

Active, not recruiting

Retinitis Pigmentosa
+6 more

Gene Therapy Product-vMCO-010
Sham Injection

Beverly Hills, California
+6 more

Jul 13, 2022

Screening for NEI Clinical Studies

Completed

Conjunctivitis
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jun 30, 2017

Retinitis, Behcet's Syndrome Trial in Tehran (Autologous Stem Cell Transplantation)

Terminated

Retinitis
Behcet's Syndrome

Autologous Stem Cell Transplantation

Tehran, Iran, Islamic Republic of

Rheumatology Research Center, Behcet's Disease Unit (Shariati Ho

Nov 9, 2015